Carole Ben-Maimon, President and CEO: Larimar Therapeutics LRMR Buy · Filed 23/05/18

Trade details

Type: Insider buy
Amount: $18,550
Shares · price: 5,000 sh · $3.71 a share
Held after: 266,829 sh
Stock: Larimar Therapeutics LRMR
Person: Carole Ben-MaimonPresident and CEO
Trade date: 23/05/17
Filed: 23/05/18
Days to filing: 1 days

3 insiders bought this week

Insiders buying this week: 3 insiders
Holding change: +1.9%

Larimar Therapeutics trades, last 26 weeks

What else happened in Larimar Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/17~23/06/16

Carole Ben-Maimon's recent trades

No other trades yet.